Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services

@article{Gomperts2008UsingTF,
  title={Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services},
  author={Rebecca Gomperts and Kinga Jelinska and S Davies and Kristina Gemzell‐Danielsson and Gunilla Kleiverda},
  journal={BJOG: An International Journal of Obstetrics \& Gynaecology},
  year={2008},
  volume={115}
}
Women on Web is a service that uses telemedicine to help women access mifepristone and misoprostol in countries with no safe care for termination of pregnancy (TOP). This study reviews the telemedicine service. After an online consultation, women with an unwanted pregnancy of up to 9 weeks are referred to a doctor. If there are no contraindications, a medical TOP is conducted by mail. After maximising the follow up from 54.8 to 77.6%, 12.6% decided not to do the TOP and 6.8% of the women who… Expand
Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services
  • J. Haldane
  • Medicine
  • BJOG : an international journal of obstetrics and gynaecology
  • 2008
TLDR
Sir, Clarity of thought may not be sufficient for the resolution of ethical questions, but it is certainly necessary for the solution of medical safety and legal liability concerns. Expand
Author response to: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services
Sir, Some of the comments in the commentaries accompanying the article Gomperts et al.1 suggest that Women on Web (WoW) is breaching domestic laws. In fact, WoW is complying with all laws. In mostExpand
Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
TLDR
It was found that telemedicine patients required more unscheduled communications and received ultrasounds far less often compared to in-clinic patients, and this information may help clinics when planning to add this service. Expand
Provision of medical abortion using telemedicine in Brazil.
TLDR
There is large need for medical abortion in Brazil and home use of mifepristone and misoprostol provided through telemedicine is safe and effective, but after 13 weeks gestation, there is an increased risk of surgical intervention that may be due to the regimen used and local clinical practices in Brazil. Expand
Use of telemedicine for providing medical abortion
  • E. Wiebe
  • Medicine
  • International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
  • 2014
TLDR
The main innovation with regard to this program is that patients see patients in their own homes using their own technology (a computer or smart phone), yet provide the same physician and counseling services as they do in the clinic. Expand
TelAbortion: evaluation of a direct to patient telemedicine abortion Service in the United States.
TLDR
This direct-to-patient telemedicine abortion service was safe, effective, efficient, and satisfactory, and has the potential to increase abortion access by enhancing the reach of providers and by offering people a new option for obtaining care conveniently and privately. Expand
[Medical abortion provided by telemedicine to women in Latin America: complications and their treatment].
TLDR
Analysis of reported complications and their treatment after a medical abortion with mifepristone and misoprostol provided by a telemedicine service to women living in Latin America seems to be a safe and effective alternative in contexts where it is legally restricted. Expand
Increasing access to medical abortion
TLDR
Increased access to medical abortion can be achieved in several ways by either increasing use of home use of misoprostol, finding new drugs without previous abortion stigma to replace mifepristone or by task shifting provision of medical abortion from physicians to midlevel providers. Expand
Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao
TLDR
Home administration of buccal misoprostol 24–36 h after mifepristone is a safe and effective method of medical abortion up to 70 days, and could be applied in a general practice in Curaçao, where induced abortion is legally restricted. Expand
Label comprehension of a combined mifepristone and misoprostol for medical abortion: a pilot study in South Africa.
TLDR
The prototype over-the-counter label for a combined mifepristone-misoprostol product for medical abortion in early pregnancy was moderately understandable to participants, but comprehension is largely a factor of literacy level. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Acceptability of home-use of misoprostol in medical abortion.
TLDR
A high acceptability among women and their partners is shown and the safety and efficacy of home-use of misoprostol is confirmed and women should be offered this choice to allow more flexibility and privacy in their abortions. Expand
Termination of pregnancy by telemedicine: an ethicist’s viewpoint
  • M. Lupton
  • Medicine
  • BJOG : an international journal of obstetrics and gynaecology
  • 2008
The opportunity to procure termination of pregnancy (TOP) over the internet, as described in the paper by Gomperts et al. on page 11711 may come as a surprise to many of the readers of this journal.Expand
[The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
TLDR
The efficacy and acceptability of mifepristone medical abortion with home administration of misoprostol provided by private practitioners linked with the hospital is evaluated and is optimistic about the expansion of medical abortion in France outside the hospital via a provider-hospital network. Expand
Frequently asked questions about medical abortion.
TLDR
Questions were sent to experts representing the fields of biomedical and clinical research, clinical practice and family planning, who conducted literature reviews so that the answers could be based on existing evidence. Expand
Review of medical abortion using mifepristone in combination with a prostaglandin analogue.
TLDR
The present review summarizes the development, physiology and the development of the currently used regimens for medical abortion with mifepristone and prostaglandin. Expand
Routine Follow-up Visits After First-Trimester Induced Abortion
TLDR
Little evidence is found that mandatory follow-up visits typically detect conditions that women themselves could not be taught to recognize, and protocols that require in-person follow-ups after abortion may not make the best use of a women's time or abilities, or of the medical system. Expand
An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 µg for first‐trimester legal medical abortion
Aim.  To evaluate the success rate of medical abortion using an outpatient regimen of oral mifepristone 400 mg and oral misoprostol 400 µg for legal abortion in women < 56 days pregnant.
Unsafe abortion: the preventable pandemic
TLDR
Ending the silent pandemic of unsafe abortion is an urgent public-health and human-rights imperative, and access to safe abortion improves women's health, and vice versa, as documented in Romania during the regime of President Nicolae Ceausescu. Expand
A comparison of women’s, providers’ and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa
TLDR
This study compares providers’ and women’s estimates of duration of pregnancy with ultrasound estimates for determining medical abortion eligibility and concludes that the former is more accurate than the latter. Expand
Efficacité et acceptabilité de l'interruption volontaire de grossesse par méthode médicamenteuse pratiquée sans hospitalisation dans le cadre d'un réseau ville–hôpital : étude prospective sur 433 patientes
Resume Objectif. – Decrire l'efficacite et acceptabilite de l'interruption volontaire de grossesse par methode medicamenteuse pratiquee sans hospitalisation dans le cadre d'un reseau ville–hopital.Expand
...
1
2
...